30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Hudson Frederick M.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hudson Frederick M.'s trades of Supernus Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-12
S Sale
12,808 -31.3%
345.46
US$3,953,014 		12,808 -31.3% 345.46 US$3,953,014
2026-03-12 2026-03-12
PrS Proposed sale
9,407
49.88
US$2,395,260 		9,407 49.88 US$2,395,260
2025-08-18 2025-08-14
S Sale
70,963 +6.2%
373.35
US$4,007,596 		70,963 +6.2% 373.35 US$4,007,596
2025-08-14 2025-08-14
PrS Proposed sale
7,457
42.26
US$315,116 		7,457 42.26 US$315,116
2024-11-12 2024-11-08
S Sale
8,722 -23.5%
36.28
US$316,434 		8,722 -23.5% 36.28 US$316,434
2024-11-08 2024-11-08
PrS Proposed sale
8,722
36.28
US$316,476 		8,722 36.28 US$316,476
2023-11-17 2023-11-15
S Sale
5,211 -13.6%
28.50
US$148,514 		5,211 -13.6% 28.50 US$148,514
2023-11-17 2023-11-15
S Sale
3,882 -9.2%
28.50
US$110,637 		3,882 -9.2% 28.50 US$110,637
2023-11-15 2023-11-15
PrS Proposed sale
3,882
28.50
US$110,655 		3,882 28.50 US$110,655
2023-11-14 2023-11-14
PrS Proposed sale
5,211
28.16
US$146,741 		5,211 28.16 US$146,741
2020-07-15 2020-07-13
PlS Planned sale
920 -4.9%
24.44
US$22,485 		920 -4.9% 24.44 US$22,485